Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("divalproex sodium")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 31

  • Page / 2
Export

Selection :

  • and

Positive response to oral Divalproex sodium (Depakote) in patients with spasticity and painZACHARIAH, S. B; BORGES, E. F; VARGHESE, R et al.The American journal of the medical sciences. 1994, Vol 308, Num 1, pp 38-40, issn 0002-9629Article

An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuseGOLDBERG, Joseph F; CLOITRE, Marylene; WHITESIDE, Joyce E et al.Current therapeutic research. 2003, Vol 64, Num 1, pp 45-54, issn 0011-393X, 10 p.Article

Fasted state bioavailability of two delayed release formulations of divalproex sodium in healthy Iranian volunteersZAKERI-MILANI, Parvin; NEMATI, Mahboob; GHANBARZADEH, Saeed et al.Arzneimittel-Forschung. 2011, Vol 61, Num 8, pp 439-443, issn 0004-4172, 5 p.Article

Divalproex Sodium -ER in Outpatients with Disruptive Behavior Disorders: A Three Month Open Label StudySAXENA, Kirti; MORA, Linda; TORRES, Erika et al.Child psychiatry and human development. 2010, Vol 41, Num 3, pp 274-284, issn 0009-398X, 11 p.Article

Extended-release divalproex in child and adolescent outpatients with epilepsyKERNITSKY, Lydia; O'HARA, Kathryn A; PING JIANG et al.Epilepsia (Copenhagen). 2005, Vol 46, Num 3, pp 440-443, issn 0013-9580, 4 p.Article

Bioavailability of Divalproex extended-release formulation relative to the Divalproex delayed-release formulationDUTTA, Sandeep; YIMING ZHANG.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 8, pp 345-352, issn 0142-2782, 8 p.Article

Single-dose kinetics and bioavailability of sodium-hydrogen divalproateANDERSON, P; ELWIN, C.-E.Clinical neuropharmacology. 1985, Vol 8, Num 2, pp 156-164, issn 0362-5664Article

Twice-daily dosing of valproate with divalproexWILDER, B. J; KARAS, B. J; HAMMOND, E. J et al.Clinical pharmacology and therapeutics. 1983, Vol 34, Num 4, pp 501-504, issn 0009-9236Article

Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapyLUNDE, Jesse L; NELSON, Robert E; STORANDT, Harrison E et al.Pharmacotherapy. 2007, Vol 27, Num 8, pp 1202-1205, issn 0277-0008, 4 p.Article

Comparison of the bioavailability of 250 and 500 mg Divalproex sodium extended-release tablets in healthy volunteersDUTTA, Sandeep; YIMING ZHANG; LEE, Lillian L et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 8, pp 353-357, issn 0142-2782, 5 p.Article

Systematic Review and Meta-Analysis of Efficacy, Safety, and Tolerability Data from Randomized Controlled Trials of Drugs Used to Treat Postherpetic NeuralgiaEDELSBERG, John S; LORD, Claudia; OSTER, Gerry et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 12, pp 1483-1490, issn 1060-0280, 8 p.Article

Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia : a literature reviewKONOVALOV, Sergiy; MURALEE, Sunanda; TAMPI, Rajesh R et al.International psychogeriatrics. 2008, Vol 20, Num 2, pp 293-308, issn 1041-6102, 16 p.Article

Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents : Results of a Stand-Alone, Long-Term Open-Label Safety StudyAPOSTOL, George; LEWIS, Donald W; LAFORET, Genevieve A et al.Headache. 2009, Vol 49, Num 1, pp 45-53, issn 0017-8748, 9 p.Article

Combination lithium and divalproex sodium in pediatric bipolar symptom restabilizationFINDLING, Robert L; MCNAMARA, Nora K; STANSBREY, Robert et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2006, Vol 45, Num 2, pp 142-148, issn 0890-8567, 7 p.Article

Elevated thyrotropin in Bipolar youths prescribed both lithium and divalproex sodiumGRACIOUS, Barbara L; FINDLING, Robert L; SEMAN, Christopher et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2004, Vol 43, Num 2, pp 215-220, issn 0890-8567, 6 p.Article

Divalproex Extended-Release in Adolescent Migraine Prophylaxis : Results of a Randomized, Double-Blind, Placebo-Controlled StudyAPOSTOL, George; CADY, Roger K; LAFORET, Genevieve A et al.Headache. 2008, Vol 48, Num 7, pp 1012-1025, issn 0017-8748, 14 p.Article

Divalproex sodium vs. valproic acid : drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorderIQBAL, S. U; CUNNINGHAM, F; LEE, A et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 6, pp 625-632, issn 0269-4727, 8 p.Article

Once-a-day controlled-release dosage form of Divalproex sodium I: Formulation design and in vitro/in vivo investigationsYIHONG QIU; CHESKIN, Howard S; ENGH, Kevin R et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 6, pp 1166-1173, issn 0022-3549, 8 p.Article

Symptomatic Response to Divalproex in Subtypes of Conduct DisorderPADHY, Ranjit; SAXENA, Kirti; REMSING, Lisa et al.Child psychiatry and human development. 2011, Vol 42, Num 5, pp 584-593, issn 0009-398X, 10 p.Article

Topiramate vs Divalproex Sodium in the Preventive Treatment of Migraine: A Prospective Real-World StudyKRYMCHANTOWSKI, Abouch V; JEVOUX, Carla C.Headache. 2011, Vol 51, Num 4, pp 554-558, issn 0017-8748, 5 p.Article

Neuromodulators for Migraine PreventionKANIECKI, Robert.Headache. 2008, Vol 48, Num 4, pp 586-600, issn 0017-8748, 15 p.Article

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorderFINDLING, Robert L; MCNAMARA, Nora K; YOUNGSTROM, Eric A et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2005, Vol 44, Num 5, pp 409-417, issn 0890-8567, 9 p.Article

Safety and Tolerability of Divalproex Sodium Extended-Release in the Prophylaxis of Migraine Headaches : Results of an Open-Label Extension Trial in AdolescentsAPOSTOL, George; PAKALNIS, Ann; LAFORET, Genevieve A et al.Headache. 2009, Vol 49, Num 1, pp 36-44, issn 0017-8748, 9 p.Article

Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trialMARTIN, C. K; HAN, H; ANTON, S. D et al.Journal of psychopharmacology (Oxford). 2009, Vol 23, Num 7, pp 814-825, issn 0269-8811, 12 p.Article

Botulinum Toxin Type A and Divalproex Sodium for Prophylactic Treatment of Episodic or Chronic MigraineBLUMENFELD, Andrew M; SCHIM, Jack D; CHIPPENDALE, Thomas J et al.Headache. 2008, Vol 48, Num 2, pp 210-220, issn 0017-8748, 11 p.Article

  • Page / 2